EGFL7 and osteosarcoma: Furthermore, overexpressed EGFL7 activates the RAS-MAPK and PI3K-Akt signaling pathways (10,11), which, in turn, regulate the pathological development of osteosarcoma according to clinical (12) and laboratory reports.